AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 46 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 35 | -95.9% | 0.00% | – |
| Q3 2018 | $3,000 | – | 858 | +12157.1% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 7 | -98.2% | 0.00% | – |
| Q4 2017 | $5,000 | -93.9% | 387 | -93.3% | 0.00% | – |
| Q3 2017 | $82,000 | +13.9% | 5,800 | +13.8% | 0.00% | – |
| Q2 2017 | $72,000 | +94.6% | 5,096 | +128.3% | 0.00% | – |
| Q1 2017 | $37,000 | +146.7% | 2,232 | +140.8% | 0.00% | – |
| Q4 2016 | $15,000 | -48.3% | 927 | -57.7% | 0.00% | – |
| Q3 2016 | $29,000 | +163.6% | 2,191 | +29.4% | 0.00% | – |
| Q2 2016 | $11,000 | -69.4% | 1,693 | -41.0% | 0.00% | – |
| Q4 2015 | $36,000 | – | 2,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |